Haemophilia

228,544 views 27 slides May 26, 2017
Slide 1
Slide 1 of 27
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27

About This Presentation

Bleeding for too long? Seek for Help immediately. Blood clotting problem is real and one can be assisted.


Slide Content

HAEMOPHILIA BY: Helao Silas

CONTENTS 1. What is hemophilia ? 2. Brief History 2.Types 3. Incidence 4. Genetics 5. Clinical presentation 6. Investigations 7. Management

What is Hemophilia? Hemophilia is a common hereditary coagulation blood disorder due to deficiency or reduced activity of clotting factor VIII or clotting factor IX. This disorder is a X- linked recessive disorder . Hemophilia is a bleeding disorder that slows down the blood clotting process. It’s transmitted via females to men who are sufferers . Female who carry a single mutated gene, are generally asymptomatic and not affected. People who have Hemophilia often have longer bleeding after some sort of contact to injury. People who have severe Hemophilia start to have spontaneous bleeding in the joints and muscles all around their bodies. Hemophilia is more common in males than females.

History of Hemophilia Best known of the hereditary bleeding disorders since 2 nd century AD, ( Talmud, Jewish rabbinical Tradition and Laws manuscripts ). First coined by Schonlein in 1820s. Originally termed “ Haemorraphilia ” i.e. love for haemorrhages but over time contracted to Hemophilia. Hemophilia is often called the disease of kings, because it was carried by many members of Europe’s royal families. Queen Victoria I of England was a carrier of haemophilia. Queen Victoria I

Inheritance of Hemophilia Hemophilia A and hemophilia B are inherited in an X-linked recessive pattern. The genes associated with these conditions are located on the X chromosome, which is one of the two sex chromosomes . In males (who have only one X chromosome ), one changed copy of the gene in each cell is sufficient to cause the condition. In females ( who have two X chromosomes ), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two changed copies of this gene, it is very rare for females to have hemophilia. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons. In X-linked recessive inheritance, a female with one changed copy of the gene in each cell is called a carrier . Carrier females have about half the usual amount of clotting factor VIII or clotting factor IX, which is generally enough for normal blood clotting. However, about 10 percent of carrier females have less than half the normal amount of one of these clotting factors; these individuals are at risk for unusual bleeding, particularly after an injury, surgery, or tooth extraction.

Haemophilia Spread Among European Royal Families

Causes of Haemophilia Hemophilia has a sex-linked recessive inheritance. In most cases Hemophilia caused by a mutation in a gene that encodes for one of the clotting factors Since the hemophilia gene is located on the X chromosome, Hemophilia usually occurs in males, and Female is the carrier of hemophilia.

Causes of Haephilia

d aa

Types: Hemophilia A- deficiency of clotting factor VIII ( X linked recessive ) Hemophilia B- deficiency of clotting factors IX ( X linked recessive ) Hemophilia C- deficiency of clotting factors XI ( Autosomal recessive ) Parahaemophilia - deficiency of clotting factor V ( Autosomal recessive ) Disease Factor deficiency Inheritance Hemophilia A VIII (8) X linked recessive Hemophilia B IX (9) X linked recessive Hemophilia C XI (11) Autosomal recessive Parahemophilia V (5) Autosomal recessive

Hemophilia A Also known as classic hemophilia or Factor VIII Deficiency People with this type of hemophilia have low levels of a blood clotting factor called figure 8 (FVIII ). It’s the most common. Mild Hemophilia A : Do NOT have spontaneous bleeding but unusual bleeding occurs with surgery and tooth extractions. People are usually diagnosed with this in later life . Moderate Hemophilia A: spontaneous bleeding, delayed oozing after minor injury, and usually diagnosed before they are 5 to 6 years old. Severe Hemophilia A: Spontaneous joint or deep muscle bleeding. Usually diagnosed within first two years of life.

Hemophilia A

Hemophilia B Also known as Christmas disease or Factor IX Deficiency People with this type of hemophilia have low levels of a blood clotting factor called figure 9 (FIX ). The two different types of hemophilia are caused by permanent gene changes (mutations). Mutations in the FVIII gene cause Hemophilia A. Mutations in the FIX gene cause Hemophilia B.

Signs and symptoms of H aemophilia Perpetuated oozing after injuries repeated bleeding after first bleeding Easy or spontaneous bruising Prolonged bleeding The most frequent symptom for Hemophilia’s types A&B is spontaneous joint bleeding . COMPLICATIONS OF HAEMPHILIA: Hemmorrhage in iliopsoas muscles Joints Intracranial bleeding

How is Hemophilia diagnosed? Hemophilia A&B are diagnosed by measuring factor clotting activity . Individuals who have Hemophilia A have low factor VIII clotting activity . Individuals who have hemophilia B have low factor IX clotting activity. Genetic testing is also available for the factor VIII gene and the factor IX gene . Genetic testing of the FVIII (F8) gene finds a disease-causing mutation in up to 98 percent of individuals who have hemophilia A. Genetic testing of the FIX gene finds disease-causing mutations in more than 99 percent of individuals who have hemophilia B. Genetic testing is usually used to identify women who are carriers of a type FVIII or FIX gene mutation, and to diagnose hemophilia in a fetus during a pregnancy. It is sometimes used to diagnose individuals who have mild symptoms of hemophilia A or B . Platelet count: Normal Bleeding time: Normal PT: Normal Clotting time & PTT: Prolonged Factor VIII or Factor IX assay: Decreased Normal values for FVIII assays are 50-150%. Values in hemophilia are as follows: Mild: >5% Moderate: 1-5% Severe: <1%

Treatment

Management Strategies Prevention of bleeding episodes. Replacement therapy. Gene Therapy Desmopressin Other therapies

1. Preventions Control Bleeding Episodes Local measures: apply direct pressure; elevate or ice compress Epistaxsis sit up lean forward

Preventions cont … Prevent joint degeneration Immobilize joint during acute bleeding Progressive exercise Avoid prolong immobility Avoid contact sports Avoid IM injections

2. Replacement therapy Fresh whole blood Whole plasma Fresh Frozen Plasma Cryoprecipitate Factor VIII or IX Concentrate Recombinant Factor VII (Novo-Seven): to bypass factor VIII in the coagulation pathway

3. Gene Therapy

4. Desmopressin Action : stimulates the release of stored factor VIII and Von Willebrand factor. Von Willebrand factor carries and binds factor VIII, which then can stay in the blood stream longer. - Administration : Injection or Nasal spray.

5. Other Treatments EACA ( e –amino caproic acid) Action : Antifibrinolytic  delays clot lysis Use : Adjuvant therapy for dental procedures Fibrin Glue: Action : Contains fibrinogen, thrombin and factor XIII. Placed in the site of injury to stabilize clot. Use : Dental procedures and after circumcision Activated Prothrombin complex concentrates Have increased amounts of activated FVIIa , factor X & thrombin. APCC are effective even in patients with high titer inhibitors. risk of thrombosis. Polyethylene glycol conjugation ( Pegylation ) Increases size, decreases renal excretion, extends half life. Polysialic acid polymers Forms a “watery cloud” around the target molecule Biodegradable.

ALWAYS DON’T FORGET…

Thank You For your Attention!! That Bleeding for long? Seek for help immediately!!!

References: Dr Suhasis Mondal “ Hemophlia ppt ” ( Dr R. Ahmed Dental College and Hospital). https:// www.slideshare.net/bhatch457/hemophilia (accessed 20 April 2017 at19h00). https://www.cdc.gov/ncbddd/hemophilia / (accessed 20 April 2017 at 20h00).